Fusion Antibodies Ltd

BT1 2WD (Unknown)

Start Date End Date Funded Value Relevance

CSV

25 50 100

Oct 17 - Sep 21

The development of bispecific antibodies to promote proapoptotic immunotherapy in pancreatic cancer

MRC award to Queen's University Belfast

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}